Growth for Good Acquisition Corporation (GFGD) Cotización

Yep and I saw where the CDC failed to release the agency's weekly publication, the Morbidity and Mortality Weekly Report, making it the first time in decades the agency has not published the highly regarded public health communication.

Here's just some of the competition for EV motorcycles:
https://evmagazine.com/articles/top-10-electric-motorcycle-companies

Won't be easy competing with brands in this business for much longer than Tomahawk or the Scarponi bros.

Adding machine learning in the form of a neural network function like the below would be next level. Version 2.0 so to speak. Something to play with once the initial 'simple' version is in hand. I work with some very bright software engineers that are interested in this too.

https:

News party back .98 + 70%

Power2 the P1ayers✅infinity Enroute!💹 ✅ 💹 💹

"....Enjoy the Show....."
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif

https://www.accessnewswire.com/newsroom/en/business-and-professional-services/greene-concepts-initiates-alliance-and-partnership-with-oman-base-974627

Outstanding went up 4.6 million but looks like they are all restricted. Let’s see if people like what they see enough to jump in anticipating growth.

🇺🇸😎🦅

“Knowing that the NIH provided Prof Liau with the funds for the basic research on Dendritic Cell Vaccines, now awaiting certification by the MHRA, my son was sufficiently worried that he sent me this YouTube”

I remember reading that NIH funding changes are coming that will tie their (

Probably not!

Thanks BB, evidently I missed that in my geography classes decades ago😂.

Maybe one of the more educated folks here can weigh in on how compassionate use programs work. Logic tells me that they just can’t go on forever without the company “splainin” how the participants are

$COEP on alert- Coeptis Therapeutics Regains Compliance with Nasdaq Listing Rule 5550(a)(2)
https://finance.yahoo.com/news/coeptis-therapeutics-regains-compliance-nasdaq-130000310.html

Ignore

I'm not selling for peanuts I already made the big money back in 2021 and I bought back in many times very low now it's time for my wife to get to retire I'm not selling for anything under $35 and maybe even higher than that... the major problem with this stock is the short interest is now up to a l

Sorry to have to keep reporting the TRUTH. Unlike Humble who has no conscience and keeps putting false outdated posts on this board rubbing salt into the wounds of the investors who don't deserve that kind of sh.t.

I seem to remember Trump suggesting making changes to short trading in the market his last term. Has there been any talk of making changes this time in office?

Top 15 at 8:35
https://ih.advfn.com/markets/nasdaq/premarket
SLXN, new to the list

the dark side of the force surround me. lol

Moreover, SGTM has a YouTube channel filled with informative videos detailing their initiatives, products, and the importance of sustainable practices. This platform serves as an excellent resource for consumers looking to learn more about green alternatives. Click here to subscribe: https://www.you

📢🚨Mr. Cooper $COOP is a 100% BUY @ barchart.com

See: https://www.barchart.com/stocks/quotes/COOP/opinion

💹wow 80-$99 INCOMING✅ UCLA💹Xerox|Mercedes|Santander|AbbeyRoadInst|Chatsworth|Ernst&Young|Omnisport|PinsentMasons
https://www.dbmmgroup.com/wp-content/uploads/2024/03/DBMM_Creds_Deck_2024_2.pdf
https://investorshub.advfn.com/uimage/uploads/2024/12/23/betnvDBMMinf

TRIB...$1.44...🥳...No Position...Will watch for possible entry...Just noticed this News...DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including

SGTM is gearing up to roll out new product lines that will soon be available at major retailers, further expanding their reach and impact. These products will focus on promoting health and sustainability, catering to the growing demand for environmentally-friendly options in the market. https://img1

It's an expensive process pulling free water out of the ground that has been sold before from a former company, that can't seem to gain traction in sales with a new company, most likely because people are wise to this water plant and the scams that pour out of it.

It's an expensive process pulling free water out of the ground that has been sold before from a former company, that can't seem to gain traction in sales with a new company, most likely because people are wise to this water plant and the scams that pour out of it.

TRIB...$1.44...🥳...No Position...Will watch for possible entry...Just noticed this News...DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including